[go: up one dir, main page]

CN101618129A - Chinese medical preparation for treating rheumatoid osteopathia - Google Patents

Chinese medical preparation for treating rheumatoid osteopathia Download PDF

Info

Publication number
CN101618129A
CN101618129A CN200910147463A CN200910147463A CN101618129A CN 101618129 A CN101618129 A CN 101618129A CN 200910147463 A CN200910147463 A CN 200910147463A CN 200910147463 A CN200910147463 A CN 200910147463A CN 101618129 A CN101618129 A CN 101618129A
Authority
CN
China
Prior art keywords
processed
medicines
radix
chinese medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910147463A
Other languages
Chinese (zh)
Other versions
CN101618129B (en
Inventor
续卫杰
贺彩珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200910147463XA priority Critical patent/CN101618129B/en
Publication of CN101618129A publication Critical patent/CN101618129A/en
Application granted granted Critical
Publication of CN101618129B publication Critical patent/CN101618129B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medical preparation for treating a rheumatoid osteopathia, comprising 18 traditional Chinese medicines in proportion: zaocys dhumnade, Chinese polyphaga, scorpio, chilopod, Chinese ephedra, rhizoma atractylodis, radix cyathulae, frankincense, myrrh, batryticated silkworm, liquorice, gentiana macrophylla, pawpaw, prepared radix angelicae sinensis with yellow rice wine, eucommia bark fried by salt, blood scorpion, nux vomica and silky ants. The preparation method comprises the following steps: sieving the medicines by a fine sieve of 60-100 meshes; sufficiently stirring to evenly mix the medicines; and filling the medicines into a No.1 capsule which comprises 0.4g of crude medicines. The Chinese medical preparation is used for treating four types of diseases: lumbar intervertebral disc protrusion, rheumarthritis, rheumatoid arthritis and soft tissue injury. By clinical tests of 200 patients, the effective rate of the Chinese medical preparation for treating rheumatoid osteopathia reaches above 96 percent and has optimal effect for lumbar intervertebral disc protrusion.

Description

A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of rheumatic osteopathia.Specifically, relate to a kind of Chinese patent medicine for the treatment of prolapse of lumbar intervertebral disc, rheumatic arthritis, rheumatoid arthritis and cartilage and soft tissue injury disease.
Background technology
Rheumatic osteopathia is a kind of common disease of harm humans health.Frequently-occurring disease is in mid-aged population, and, the rejuvenation year by year of falling ill in recent years.Its sickness rate height, only domestic rheumatic osteopathia patient is just up to more than 8,000 ten thousand people, and disability rate is also quite high.
In recent years, the treatment prolapse of lumbar intervertebral disc is many treats with operation method.It is big to exist operation risk, and the drawback of recurrence again after the most of patients operation; And manual reduction can't be repaired the fibrous ring and the cartilaginous tissue of destroyed again.For other rheumatic osteopathia, doctor trained in Western medicine multiselect NSAID (non-steroidal anti-inflammatory drug).As auranofin, penicillamine, immunosuppressant and adrenocortical hormone etc.The said medicine toxic and side effects is big, hepatic and renal function is formed destroy.Take for a long time and will cause the patient to make the matter worse.Though traditional Chinese medical science medicine does not have great toxic and side effects, comprise that unguentum, ball class kind are quite a few, how with collateral dredging invigorate blood circulation, reducing swelling and alleviating pain, paralysis nerve, be main at rheumatism.Acid after the drug withdrawal, expand, stiff, symptom such as take out, ache new line is arranged again, disease can not get effecting a radical cure.Specially at rheumatic osteopathia, treating both the principal and secondary aspects of a disease belongs to blank on the Chinese patent medicine that can cure.
Summary of the invention
The present invention has overcome the shortcomings and deficiencies of prior art, and a kind of Chinese medicine preparation for the treatment of rheumatic osteopathia is provided.Concrete technical scheme is summarized as follows:
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention, it by Zaocys, Eupolyphaga Seu Steleophaga, Scorpio, Scolopendra, Herba Ephedrae, Rhizoma Atractylodis, Radix Cyathulae, Olibanum (processed), Myrrha (processed), Bombyx Batryticatus, Radix Glycyrrhizae, Radix Gentianae Macrophyllae, Fructus Chaenomelis, Radix Angelicae Sinensis (processed with wine), Cortex Eucommiae (parched with salt), Sanguis Draxonis, Semen Strychni(processed), Formica fusca totally ten eight the flavor Chinese medicines form.
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention, 18 contained flavor Chinese medicines, remove Scolopendra, concrete prescriptions of remaining 17 flavor Chinese medicine are: Zaocys, Scorpio, Herba Ephedrae, Rhizoma Atractylodis, Radix Cyathulae, Olibanum (processed), Myrrha (processed), Bombyx Batryticatus, Radix Glycyrrhizae, respectively account for 5~7%; Semen Strychni(processed), Radix Gentianae Macrophyllae, Fructus Chaenomelis, Sanguis Draxonis respectively account for 3~4%; Formica fusca, Cortex Eucommiae (parched with salt) respectively account for 10~13%; Radix Angelicae Sinensis (processed with wine), Eupolyphaga Seu Steleophaga respectively account for 2~4%.The total amount of 17 flavor Chinese medicines is 100%.
A kind of ratio for the treatment of the contained Scolopendra of Chinese medicine preparation of rheumatic osteopathia of the present invention is: the gross weight with all the other 17 flavor Chinese medicines is a radix, and per 100 grams add 1~2 of Scolopendra.
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention, concrete pharmaceutical methods is: contained 18 flavor Chinese medicines all are developed into powder, and cross 60~100 mesh sieves, fully stir and make it evenly mixed, adorn capsule then No. 1, make every capsules contain crude drug 0,4 grams.
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention, its instructions of taking and consumption are: every day 2~3 times, each 3~5, under yellow wine or eliminating cold for resuscitation water clothes.10~30 days is a course of treatment.
Compared with prior art, the invention has the beneficial effects as follows: can treat arthroncus, pain, cartilage and soft tissue pain's disease that each rheumatoid osteopathia causes effectively.Through more than 2 years to 200 routine rheumatic osteopathia patients' clinical practice, obtained curative effect preferably, obvious effective rate is up to more than 96%.Especially prolapse of lumbar intervertebral disc is had specially good effect, details are as follows for relevant clinical treatment situation:
One, among the physical data 200 routine patients, male 103 examples, women 97 examples.
Two, the age: generally between 26~64 years old, 45 years old mean age was many with person in middle and old age.Main morbidity.About 30~60 years old age.
Three, course of disease situation: two months with interior 31 examples, more than two months to 1 year 69 example, more than 1 year to 3 years 32 examples, more than 3 years to 5 years 35 examples, more than 5 years to 10 years 13 examples, 20 examples more than 10 years.
Four, typing;
1, presses the western medicine typing: rheumatic arthritis 73 examples, rheumatoid arthritis 17 examples, prolapse of lumbar intervertebral disc 96 examples, cartilage and soft tissue injury 14 examples.
2, by the Chinese medicine typing: migratory arthralgia (wind heavy type) 50 examples, arthralgia aggravated by cold (cold heavy) 74 examples, damp arthralgia (weight in wet base type) 46 examples, pyretic arthralgia (damp-heat type) 30 examples.
Five, treatment standard
1, clinical cure: pain disappears, and swelling is disappeared, joint stiff disappearance the in morning, and restore or control in the distortion joint, does not influence life, activity.
2, produce effects: pain disappears substantially, and other sign obviously alleviates.
3, invalid: as to take week back a symptom or a Signs no change or increase the weight of.
Six, curative effect is summed up:
Clinical cure 114 examples, produce effects 82 examples, invalid 4 examples, total effective rate 98%.
By the clinical practice to Chinese medicine preparation of the present invention, the treatment rheumatic osteopathia has been received satisfied curative effect.The rheumatic osteopathia symptom is a lot, and the clinical practice of this group is got rid of organic disease (as tumor) in functional category.This group selects for use clinical common prolapse of lumbar intervertebral disc, rheumatic arthritis, rheumatoid arthritis, cartilage and four types of soft tissue injury to carry out clinical treatment.Most of patients was taken the Western medicine hormone before this group case treatment, and because of toxic and side effects is stopped using, some patient carried out treatments such as the taking orally of the traditional Chinese medical science, external application, acupuncture.In taking the process of preparation of the present invention, must not take Western medicine hormone and other Chinese Traditional Medicines.
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention has that nourishing the liver and kidney, invigorating the spleen for eliminating dampness, strengthening the tendons and bones, detumescence relieve the pain, promoting flow of qi by warming channel, dispels the effect of rheumatism, and the most effective to repairing bone lesion.The treatment rheumatic osteopathia is the most remarkable, and its effective percentage is up to more than 96%.To the prolapse of lumbar intervertebral disc best results.
Specific embodiments
Because of summary of the invention is described in detail, no longer repeat herein.

Claims (4)

1 one kinds of Chinese medicine preparation for the treatment of rheumatic osteopathia, it is characterized in that, it by Zaocys, Eupolyphaga Seu Steleophaga, Scorpio, Scolopendra, Herba Ephedrae, Rhizoma Atractylodis, Radix Cyathulae, Olibanum (processed), Myrrha (processed), Bombyx Batryticatus, Radix Glycyrrhizae, Radix Gentianae Macrophyllae, Fructus Chaenomelis, Radix Angelicae Sinensis (processed with wine), Cortex Eucommiae (parched with salt), Sanguis Draxonis, Semen Strychni(processed), Formica fusca totally ten eight the flavor Chinese medicines form.
2, a kind of Chinese medicine preparation for the treatment of rheumatic osteopathia according to claim 1, it is characterized in that, above-mentioned 18 flavor Chinese medicines are removed Scolopendra, and the concrete proportioning of other 17 flavor Chinese medicine is: Zaocys, Scorpio, Herba Ephedrae, Rhizoma Atractylodis, Radix Cyathulae, Olibanum (processed), Myrrha (processed), Bombyx Batryticatus, Radix Glycyrrhizae respectively account for 5--7%; Semen Strychni(processed), Radix Gentianae Macrophyllae, Fructus Chaenomelis, Sanguis Draxonis respectively account for 3--4%; Formica fusca, Cortex Eucommiae (parched with salt) respectively account for 10--13%; Eupolyphaga Seu Steleophaga, Radix Angelicae Sinensis (processed with wine) respectively account for 2--4%, and 17 flavor Chinese medicine total amounts are 100%.
3, a kind of Chinese medicine preparation for the treatment of rheumatic osteopathia according to claim 1 is characterized in that the ratio of contained Scolopendra is: the gross weight with other 17 flavor Chinese medicines is a radix, and per 100 grams add Scolopendra 1--2 bar.
4, a kind of Chinese medicine preparation for the treatment of rheumatic osteopathia according to claim 1 is characterized in that, contained 18 flavor Chinese medicines all are developed into powder, and cross the 60--100 mesh sieve, fully stir and make it evenly mixed, adorn capsule then No. 1, make every capsules contain crude drug 0,4 grams.
CN200910147463XA 2009-06-09 2009-06-09 Chinese medical preparation for treating rheumatoid osteopathia Expired - Fee Related CN101618129B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910147463XA CN101618129B (en) 2009-06-09 2009-06-09 Chinese medical preparation for treating rheumatoid osteopathia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910147463XA CN101618129B (en) 2009-06-09 2009-06-09 Chinese medical preparation for treating rheumatoid osteopathia

Publications (2)

Publication Number Publication Date
CN101618129A true CN101618129A (en) 2010-01-06
CN101618129B CN101618129B (en) 2011-10-12

Family

ID=41511657

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910147463XA Expired - Fee Related CN101618129B (en) 2009-06-09 2009-06-09 Chinese medical preparation for treating rheumatoid osteopathia

Country Status (1)

Country Link
CN (1) CN101618129B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103100077A (en) * 2013-03-08 2013-05-15 薛春元 Medicine for treating chronic rheumatoid bone diseases and preparation method of medicine
CN106176946A (en) * 2015-05-07 2016-12-07 沈春雷 A kind of Chinese medicine formula and preparation method thereof
CN106511730A (en) * 2017-01-03 2017-03-22 周怀明 Prominent technology application of acupuncture in treating rheumatism bone diseases
CN106668231A (en) * 2015-11-10 2017-05-17 马福奎 Traditional Chinese medicine for treating protrusion of lumbar intervertebral disc

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103100077A (en) * 2013-03-08 2013-05-15 薛春元 Medicine for treating chronic rheumatoid bone diseases and preparation method of medicine
CN103100077B (en) * 2013-03-08 2014-12-31 薛春元 Medicine for treating chronic rheumatoid bone diseases and preparation method of medicine
CN106176946A (en) * 2015-05-07 2016-12-07 沈春雷 A kind of Chinese medicine formula and preparation method thereof
CN106668231A (en) * 2015-11-10 2017-05-17 马福奎 Traditional Chinese medicine for treating protrusion of lumbar intervertebral disc
CN106511730A (en) * 2017-01-03 2017-03-22 周怀明 Prominent technology application of acupuncture in treating rheumatism bone diseases

Also Published As

Publication number Publication date
CN101618129B (en) 2011-10-12

Similar Documents

Publication Publication Date Title
CN102488869B (en) Traditional Chinese medicinal external-use liniment for muscle and bone ache
CN101618129B (en) Chinese medical preparation for treating rheumatoid osteopathia
CN101214357A (en) Pharmaceutical composition for treating chronic prostatitis
CN102085299B (en) Chinese patent medicine for treating prostatitis and preparation method thereof
CN105362491A (en) External-use medicine for treating cervical vertebra hyperosteogeny
CN101664455A (en) Chinese medicinal composition for treating lumbago and preparation method
CN1078081C (en) Medicine for treating osteoproliferation, rheumatism and rheumatoid arthritis, and preparing method thereof
CN100333738C (en) Chinese medicinal ointment for treating bone diseases
CN117599125A (en) A Chinese medicinal composition for supplementing calcium and strengthening bones for treating osteoporosis, and its preparation method and application
CN104547961A (en) Traditional Chinese medicine composition for treating gallstones
CN101317958B (en) Medicament for treating uarthritis, that is Tongfengning capsule and preparation method thereof
CN100352465C (en) Medicinal liquor for treating rheumatic arthrolithiasis and its preparing method
CN106177002A (en) A kind of medicated powder medicated wine complex treating bone matrix hyperplasia
CN106038881A (en) Medicinal liquor for treating gout and preparation method of medicinal liquor
CN112755134B (en) Plaster for treating hyperosteogeny and preparation method thereof
CN116942740B (en) Traditional Chinese medicine composition for treating lumbar disc herniation and application thereof
CN108310163A (en) A kind of dispelling wind-evil and wetness-evil blood-activating Chinese medicine preparation and preparation method thereof
CN100509003C (en) Medicament of treating psoriasis
CN1322886C (en) Plaster for treating pain and prpearation thereof
CN1424104A (en) Medicines for treating chronic prostatitis and preparation thereof
CN105998519A (en) Oral medicine for treating frequent micturition due to pelvic inflammatory disease
CN105343862A (en) Drug composition for soft tissue injury and fracture
CN105381168A (en) Backache relieving drug and preparation method thereof
CN105641586A (en) Fengtongning preparation and preparation method thereof
CN106166206A (en) A kind of gynecological inflammation causes the rehabilitation medicine preparation method of frequent micturition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111012

Termination date: 20130609